As of March 2024 NeoGenomics has a market cap of $2.00 Billion. This makes NeoGenomics the world's 4127th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.00 B | -2.73% |
2023 | $2.06 B | 76.72% |
2022 | $1.16 B | -72.22% |
2021 | $4.20 B | -29.72% |
2020 | $5.97 B | 95.04% |
2019 | $3.06 B | 157.29% |
2018 | $1.19 B | 67.2% |
2017 | $0.71 B | 5.88% |
2016 | $0.67 B | 12.76% |
2015 | $0.59 B | 137.53% |
2014 | $0.25 B | 41.28% |
2013 | $0.17 B | 58.34% |
2012 | $0.11 B | 85.52% |
2011 | $60.53 M | 24.42% |
2010 | $48.65 M | -12.78% |
2009 | $55.77 M | 188.34% |
2008 | $19.34 M | -42.94% |
2007 | $33.9 M | -16.48% |
2006 | $40.59 M | 835.52% |
2005 | $4.33 M | -19.42% |
2004 | $5.38 M | 483.74% |
2003 | $0.92 M | -74.27% |
2002 | $3.58 M | -40.97% |
2001 | $6.07 M |
On Mar 28th, 2024 the market cap of NeoGenomics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | $14.73 B | 634.60% | ๐บ๐ธ USA |
LabCorp LH | $18.37 B | 815.86% | ๐บ๐ธ USA |
RadNet RDNT | $3.58 B | 78.79% | ๐บ๐ธ USA |
Psychemedics PMD | $16.99 M | -99.15% | ๐บ๐ธ USA |
Enzo Biochem ENZ | $65.05 M | -96.76% | ๐บ๐ธ USA |